Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 137

1.

Epigenetic downregulation of TET3 reduces genome-wide 5hmC levels and promotes glioblastoma tumorigenesis.

Carella A, Tejedor JR, García MG, Urdinguio RG, Bayón GF, Sierra M, López V, García-Toraño E, Santamarina-Ojeda P, Pérez RF, Bigot T, Mangas C, Corte-Torres MD, Sáenz-de-Santa-María I, Mollejo M, Meléndez B, Astudillo A, Chiara MD, Fernández AF, Fraga MF.

Int J Cancer. 2019 Jun 18. doi: 10.1002/ijc.32520. [Epub ahead of print]

PMID:
31211412
2.

Advanced-stage mycosis fungoides: role of the signal transducer and activator of transcription 3, nuclear factor-κB and nuclear factor of activated T cells pathways.

Pérez C, Mondéjar R, García-Díaz N, Cereceda L, León A, Montes S, Durán Vian C, Pérez Paredes MG, González-Morán A, Alegre de Miguel V, Sanz Anquela JM, Frias J, Limeres MA, González LM, Martín Dávila F, Beltrán M, Mollejo M, Méndez JR, González MA, González García J, López R, Gómez A, Izquierdo F, Ramos R, Camacho C, Rodriguez-Pinilla SM, Martínez N, Vaqué JP, Ortiz-Romero PL, Piris MA.

Br J Dermatol. 2019 May 3. doi: 10.1111/bjd.18098. [Epub ahead of print]

PMID:
31049933
3.

Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma.

González-Rincón J, Méndez M, Gómez S, García JF, Martín P, Bellas C, Pedrosa L, Rodríguez-Pinilla SM, Camacho FI, Quero C, Pérez-Callejo D, Rueda A, Llanos M, Gómez-Codina J, Piris MA, Montes-Moreno S, Bárcena C, Rodríguez-Abreu D, Menárguez J, de la Cruz-Merino L, Monsalvo S, Parejo C, Royuela A, Kwee I, Cascione L, Arribas A, Bertoni F, Mollejo M, Provencio M, Sánchez-Beato M.

PLoS One. 2019 Feb 25;14(2):e0212813. doi: 10.1371/journal.pone.0212813. eCollection 2019.

4.

Disease-biased and shared characteristics of the immunoglobulin gene repertoires in marginal zone B cell lymphoproliferations.

Xochelli A, Bikos V, Polychronidou E, Galigalidou C, Agathangelidis A, Charlotte F, Moschonas P, Davis Z, Colombo M, Roumelioti M, Sutton LA, Groenen P, van den Brand M, Boudjoghra M, Algara P, Traverse-Glehen A, Ferrer A, Stalika E, Karypidou M, Kanellis G, Kalpadakis C, Mollejo M, Pangalis G, Vlamos P, Amini RM, Pospisilova S, Gonzalez D, Ponzoni M, Anagnostopoulos A, Giudicelli V, Lefranc MP, Espinet B, Panagiotidis P, Piris MA, Du MQ, Rosenquist R, Papadaki T, Belessi C, Ferrarini M, Oscier D, Tzovaras D, Ghia P, Davi F, Hadzidimitriou A, Stamatopoulos K.

J Pathol. 2019 Apr;247(4):416-421. doi: 10.1002/path.5209. Epub 2019 Jan 30.

PMID:
30484876
5.

Molecular Study of Long-Term Survivors of Glioblastoma by Gene-Targeted Next-Generation Sequencing.

Cantero D, Rodríguez de Lope Á, Moreno de la Presa R, Sepúlveda JM, Borrás JM, Castresana JS, D'Haene N, García JF, Salmon I, Mollejo M, Rey JA, Hernández-Laín A, Meléndez B.

J Neuropathol Exp Neurol. 2018 Aug 1;77(8):710-716. doi: 10.1093/jnen/nly048.

PMID:
30010995
6.

Spontaneously Ruptured Spleen Samples in Patients With Infectious Mononucleosis: Analysis of Histology and Lymphoid Subpopulations.

Siliézar MM, Muñoz CC, Solano-Iturri JD, Ortega-Comunian L, Mollejo M, Montes-Moreno S, Piris MA.

Am J Clin Pathol. 2018 Aug 30;150(4):310-317. doi: 10.1093/ajcp/aqy056.

PMID:
30007337
7.

Loss of 5hmC identifies a new type of aberrant DNA hypermethylation in glioma.

Fernandez AF, Bayón GF, Sierra MI, Urdinguio RG, Toraño EG, García MG, Carella A, López V, Santamarina P, Pérez RF, Belmonte T, Tejedor JR, Cobo I, Menendez P, Mangas C, Ferrero C, Rodrigo L, Astudillo A, Ortea I, Cueto Díaz S, Rodríguez-Gonzalez P, García Alonso JI, Mollejo M, Meléndez B, Domínguez G, Bonilla F, Fraga MF.

Hum Mol Genet. 2018 Sep 1;27(17):3046-3059. doi: 10.1093/hmg/ddy214.

PMID:
29878202
8.

Mutations in the JAK/STAT pathway genes and activation of the pathway, a relevant finding in nodal Peripheral T-cell lymphoma.

Manso R, Sánchez-Beato M, González-Rincón J, Gómez S, Rojo F, Mollejo M, García-Cosio M, Menárguez J, Piris MA, Rodríguez-Pinilla SM.

Br J Haematol. 2018 Nov;183(3):497-501. doi: 10.1111/bjh.14984. Epub 2017 Oct 26. No abstract available.

PMID:
29076126
9.

Erythema multiforme-like reaction resulting from vitamin K1 oxide (phytomenadione epoxide).

Pastor-Nieto MA, Gatica-Ortega ME, Melgar-Molero V, González-Muñoz P, Mollejo M, Schoendorff C, De Eusebio-Murillo E.

Contact Dermatitis. 2017 Nov;77(5):343-345. doi: 10.1111/cod.12837. No abstract available.

PMID:
29063687
10.

Comment on: "A Unique Clinicopathological Manifestation of Fungal Infection: A Case Series of Deep Dermatophytosis in Immunosuppressed Patients".

González-Cantero Á, Honorato-Guerra S, Sánchez-Moya AI, Arias-Santiago S, Moreno-Torres B, Martinez-Lorenzo E, Mollejo M, Schoendorff-Ortega C.

Am J Clin Dermatol. 2017 Oct;18(5):709-711. doi: 10.1007/s40257-017-0309-6. No abstract available.

PMID:
28653140
11.

Clinical and diagnostic relevance of NOTCH2-and KLF2-mutations in splenic marginal zone lymphoma.

Campos-Martín Y, Martínez N, Martínez-López A, Cereceda L, Casado F, Algara P, Oscier D, Menarguez FJ, García JF, Piris MA, Mollejo M.

Haematologica. 2017 Aug;102(8):e310-e312. doi: 10.3324/haematol.2016.161711. Epub 2017 May 18. No abstract available.

12.

Splenic marginal zone lymphoma.

Piris MA, Onaindía A, Mollejo M.

Best Pract Res Clin Haematol. 2017 Mar - Jun;30(1-2):56-64. doi: 10.1016/j.beha.2016.09.005. Epub 2016 Nov 5. Review.

PMID:
28288718
13.

Intravascular large B-cell lymphoma in a kidney biopsy.

Diaz-Crespo F, Mollejo M.

Blood. 2016 Jun 9;127(23):2939. doi: 10.1182/blood-2016-02-697490. Epub 2016 Jun 9. No abstract available.

14.

Splenic diffuse red pulp small B-cell lymphoma displays increased expression of cyclin D3 and recurrent CCND3 mutations.

Curiel-Olmo S, Mondéjar R, Almaraz C, Mollejo M, Cereceda L, Marès R, Derdak S, Campos-Martín Y, Batlle A, González de Villambrosía S, Gut M, Blanc J, Traverse-Glehen A, Verney A, Baseggio L, Camacho FI, Wotherspoon A, Stamatopoulos K, Xochelli A, Papadaki T, Kanellis G, Ponzoni M, García-Cosío M, Vaqué JP, Beltrán S, Gut I, Piris MA, Martínez N.

Blood. 2017 Feb 23;129(8):1042-1045. doi: 10.1182/blood-2016-11-751024. Epub 2017 Jan 9. No abstract available.

15.

Shared Oncogenic Pathways Implicated in Both Virus-Positive and UV-Induced Merkel Cell Carcinomas.

González-Vela MDC, Curiel-Olmo S, Derdak S, Beltran S, Santibañez M, Martínez N, Castillo-Trujillo A, Gut M, Sánchez-Pacheco R, Almaraz C, Cereceda L, Llombart B, Agraz-Doblas A, Revert-Arce J, López Guerrero JA, Mollejo M, Marrón PI, Ortiz-Romero P, Fernandez-Cuesta L, Varela I, Gut I, Cerroni L, Piris MÁ, Vaqué JP.

J Invest Dermatol. 2017 Jan;137(1):197-206. doi: 10.1016/j.jid.2016.08.015. Epub 2016 Sep 1.

16.

Imatinib in systemic mastocytosis: a phase IV clinical trial in patients lacking exon 17 KIT mutations and review of the literature.

Alvarez-Twose I, Matito A, Morgado JM, Sánchez-Muñoz L, Jara-Acevedo M, García-Montero A, Mayado A, Caldas C, Teodósio C, Muñoz-González JI, Mollejo M, Escribano L, Orfao A.

Oncotarget. 2016 Jul 19;8(40):68950-68963. doi: 10.18632/oncotarget.10711. eCollection 2017 Sep 15.

17.

Glomerular C3d as a novel prognostic marker for renal vasculitis.

Villacorta J, Diaz-Crespo F, Acevedo M, Guerrero C, Campos-Martin Y, García-Díaz E, Mollejo M, Fernandez-Juarez G.

Hum Pathol. 2016 Oct;56:31-9. doi: 10.1016/j.humpath.2016.05.015. Epub 2016 May 30.

PMID:
27257040
18.

C-MYC is related to GATA3 expression and associated with poor prognosis in nodal peripheral T-cell lymphomas.

Manso R, Bellas C, Martín-Acosta P, Mollejo M, Menárguez J, Rojo F, Llamas P, Piris MA, Rodríguez-Pinilla SM.

Haematologica. 2016 Aug;101(8):e336-8. doi: 10.3324/haematol.2016.143768. Epub 2016 May 5. No abstract available.

19.

p-MAPK1 expression associated with poor prognosis in angioimmunoblastic T-cell lymphoma patients.

Manso R, Roncador G, Montes-Moreno S, Rojo F, Pérez-Sáenz MÁ, Mollejo M, Menárguez J, Carvajal N, García-Cosio M, Llamas P, Piris MA, Rodríguez-Pinilla SM.

Br J Haematol. 2017 Feb;176(4):661-664. doi: 10.1111/bjh.13972. Epub 2016 Feb 25. No abstract available.

PMID:
26915336
20.

Stratifying diffuse large B-cell lymphoma patients treated with chemoimmunotherapy: GCB/non-GCB by immunohistochemistry is still a robust and feasible marker.

Batlle-López A, González de Villambrosía S, Francisco M, Malatxeberria S, Sáez A, Montalban C, Sánchez L, Garcia J, González-Barca E, López-Hernández A, Ruiz-Marcellan MC, Mollejo M, Grande C, Richards KL, Hsi ED, Tzankov A, Visco C, Xu-Monette ZY, Cao X, Young KH, Piris MÁ, Conde E, Montes-Moreno S.

Oncotarget. 2016 Apr 5;7(14):18036-49. doi: 10.18632/oncotarget.7495.

21.

Complete response to gemtuzumab ozogamicin in a patient with refractory mast cell leukemia.

Alvarez-Twose I, Martínez-Barranco P, Gotlib J, García-Montero A, Morgado JM, Jara-Acevedo M, Merker JD, Peñalver FJ, Matito A, Hou Y, Sánchez-Muñoz L, Mayado A, Mollejo M, Escribano L, Orfao A.

Leukemia. 2016 Aug;30(8):1753-6. doi: 10.1038/leu.2016.30. Epub 2016 Feb 15. No abstract available.

PMID:
26876592
22.

An Immunogenetic Signature of Ongoing Antigen Interactions in Splenic Marginal Zone Lymphoma Expressing IGHV1-2*04 Receptors.

Bikos V, Karypidou M, Stalika E, Baliakas P, Xochelli A, Sutton LA, Papadopoulos G, Agathangelidis A, Papadopoulou E, Davis Z, Algara P, Kanellis G, Traverse-Glehen A, Mollejo M, Anagnostopoulos A, Ponzoni M, Gonzalez D, Pospisilova S, Matutes E, Piris MA, Papadaki T, Ghia P, Rosenquist R, Oscier D, Darzentas N, Tzovaras D, Belessi C, Hadzidimitriou A, Stamatopoulos K.

Clin Cancer Res. 2016 Apr 15;22(8):2032-40. doi: 10.1158/1078-0432.CCR-15-1170. Epub 2015 Dec 8.

23.

Diagnosis and classification of mastocytosis in non-specialized versus reference centres: a Spanish Network on Mastocytosis (REMA) study on 122 patients.

Sánchez-Muñoz L, Morgado JM, Álvarez-Twose I, Matito A, Garcia-Montero AC, Teodosio C, Jara-Acevedo M, Mayado A, Mollejo M, Caldas C, González de Olano D, Escribano L, Orfao A.

Br J Haematol. 2016 Jan;172(1):56-63. doi: 10.1111/bjh.13789. Epub 2015 Oct 12.

PMID:
26456532
24.

Antineutrophil cytoplasmic antibody negative pauci-immune extracapillary glomerulonephritis.

Villacorta J, Diaz-Crespo F, Acevedo M, Guerrero C, Mollejo M, Fernandez-Juarez G.

Nephrology (Carlton). 2016 Apr;21(4):301-7. doi: 10.1111/nep.12608.

PMID:
26369898
25.

Secretory meningioma with KLF4 K409Q mutation in collision with glioma.

Ruiz J, Capilla E, Díaz JF, Ruiz JA, Andrade J, Hernández T, Mollejo M, Meléndez B.

Clin Neuropathol. 2015 Nov-Dec;34(6):322-9. doi: 10.5414/NP300860.

PMID:
26227255
26.

Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis.

Álvarez-Twose I, Jara-Acevedo M, Morgado JM, García-Montero A, Sánchez-Muñoz L, Teodósio C, Matito A, Mayado A, Caldas C, Mollejo M, Orfao A, Escribano L.

J Allergy Clin Immunol. 2016 Jan;137(1):168-178.e1. doi: 10.1016/j.jaci.2015.05.008. Epub 2015 Jun 19.

PMID:
26100086
27.

MYD88 (L265P) somatic mutation in marginal zone B-cell lymphoma.

Martinez-Lopez A, Curiel-Olmo S, Mollejo M, Cereceda L, Martinez N, Montes-Moreno S, Almaraz C, Revert JB, Piris MA.

Am J Surg Pathol. 2015 May;39(5):644-51. doi: 10.1097/PAS.0000000000000411.

PMID:
25723115
28.

Impact on prognosis of the regional distribution of MGMT methylation with respect to the CpG island methylator phenotype and age in glioma patients.

Mur P, Rodríguez de Lope Á, Díaz-Crespo FJ, Hernández-Iglesias T, Ribalta T, Fiaño C, García JF, Rey JA, Mollejo M, Meléndez B.

J Neurooncol. 2015 May;122(3):441-50. doi: 10.1007/s11060-015-1738-9. Epub 2015 Feb 15.

PMID:
25682093
29.

Molecular classification defines 4 prognostically distinct glioma groups irrespective of diagnosis and grade.

Mur P, Mollejo M, Hernández-Iglesias T, de Lope ÁR, Castresana JS, García JF, Fiaño C, Ribalta T, Rey JA, Meléndez B.

J Neuropathol Exp Neurol. 2015 Mar;74(3):241-9. doi: 10.1097/NEN.0000000000000167.

PMID:
25668564
30.

DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic features.

Arribas AJ, Rinaldi A, Mensah AA, Kwee I, Cascione L, Robles EF, Martinez-Climent JA, Oscier D, Arcaini L, Baldini L, Marasca R, Thieblemont C, Briere J, Forconi F, Zamò A, Bonifacio M, Mollejo M, Facchetti F, Dirnhofer S, Ponzoni M, Bhagat G, Piris MA, Gaidano G, Zucca E, Rossi D, Bertoni F.

Blood. 2015 Mar 19;125(12):1922-31. doi: 10.1182/blood-2014-08-596247. Epub 2015 Jan 22.

31.

Chronic lymphocytic leukemia cells in lymph nodes show frequent NOTCH1 activation.

Onaindia A, Gómez S, Piris-Villaespesa M, Martínez-Laperche C, Cereceda L, Montes-Moreno S, Batlle A, de Villambrosia SG, Pollán M, Martín-Acosta P, González-Rincón J, Menarguez J, Alvés J, Rodriguez-Pinilla SM, García JF, Mollejo M, Fraga M, García-Marco JA, Piris MA, Sánchez-Beato M.

Haematologica. 2015 May;100(5):e200-3. doi: 10.3324/haematol.2014.117705. Epub 2014 Dec 31. No abstract available.

32.

PIM kinases as potential therapeutic targets in a subset of peripheral T cell lymphoma cases.

Martín-Sánchez E, Odqvist L, Rodríguez-Pinilla SM, Sánchez-Beato M, Roncador G, Domínguez-González B, Blanco-Aparicio C, García Collazo AM, Cantalapiedra EG, Fernández JP, Curiel del Olmo S, Pisonero H, Madureira R, Almaraz C, Mollejo M, Alves FJ, Menárguez J, González-Palacios F, Rodríguez-Peralto JL, Ortiz-Romero PL, Real FX, García JF, Bischoff JR, Piris MA.

PLoS One. 2014 Nov 11;9(11):e112148. doi: 10.1371/journal.pone.0112148. eCollection 2014.

33.

The RHOA G17V gene mutation occurs frequently in peripheral T-cell lymphoma and is associated with a characteristic molecular signature.

Manso R, Sánchez-Beato M, Monsalvo S, Gómez S, Cereceda L, Llamas P, Rojo F, Mollejo M, Menárguez J, Alves J, García-Cosio M, Piris MA, Rodríguez-Pinilla SM.

Blood. 2014 May 1;123(18):2893-4. doi: 10.1182/blood-2014-02-555946. No abstract available.

34.

NFκB expression is a feature of both activated B-cell-like and germinal center B-cell-like subtypes of diffuse large B-cell lymphoma.

Odqvist L, Montes-Moreno S, Sánchez-Pacheco RE, Young KH, Martín-Sánchez E, Cereceda L, Sánchez-Verde L, Pajares R, Mollejo M, Fresno MF, Mazorra F, Ruíz-Marcellán C, Sánchez-Beato M, Piris MA.

Mod Pathol. 2014 Oct;27(10):1331-7. doi: 10.1038/modpathol.2014.34. Epub 2014 Mar 7.

35.

Genome-wide DNA profiling identifies clonal heterogeneity in marginal zone lymphomas.

Mian M, Kwee I, Rinaldi A, Ponzoni M, Bhagat G, Rossi D, Arcaini L, Gascoyne RD, Mollejo M, Baldini L, Thieblemont C, Gaidano G, Zucca E, Bertoni F.

Br J Haematol. 2014 Mar;164(6):896-9. doi: 10.1111/bjh.12688. Epub 2013 Dec 11. No abstract available.

PMID:
24329863
36.

Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation.

Martínez N, Almaraz C, Vaqué JP, Varela I, Derdak S, Beltran S, Mollejo M, Campos-Martin Y, Agueda L, Rinaldi A, Kwee I, Gut M, Blanc J, Oscier D, Strefford JC, Martinez-Lopez J, Salar A, Sole F, Rodriguez-Peralto JL, Diez-Tascón C, García JF, Fraga M, Sebastián E, Alvés J, Menárguez J, González-Carreró J, Casado LF, Bayes M, Bertoni F, Gut I, Piris MA.

Leukemia. 2014 Jun;28(6):1334-40. doi: 10.1038/leu.2013.365. Epub 2013 Dec 3.

PMID:
24296945
37.

Short-term omalizumab treatment in an adolescent with cutaneous mastocytosis.

Matito A, Blázquez-Goñi C, Morgado JM, Alvarez-Twose I, Mollejo M, Sánchez-Muñoz L, Escribano L.

Ann Allergy Asthma Immunol. 2013 Nov;111(5):425-6. doi: 10.1016/j.anai.2013.08.014. Epub 2013 Sep 21. No abstract available.

PMID:
24125156
38.

CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis.

Morgado JM, Perbellini O, Johnson RC, Teodósio C, Matito A, Álvarez-Twose I, Bonadonna P, Zamò A, Jara-Acevedo M, Mayado A, Garcia-Montero A, Mollejo M, George TI, Zanotti R, Orfao A, Escribano L, Sánchez-Muñoz L.

Histopathology. 2013 Dec;63(6):780-7. doi: 10.1111/his.12221. Epub 2013 Sep 20.

PMID:
24111625
39.

Hepatitis C virus-related lymphoproliferative disorders encompass a broader clinical and morphological spectrum than previously recognized: a clinicopathological study.

Mollejo M, Menárguez J, Guisado-Vasco P, Bento L, Algara P, Montes-Moreno S, Rodriguez-Pinilla MS, Cruz MA, Casado F, Montalbán C, Piris MA.

Mod Pathol. 2014 Feb;27(2):281-93. doi: 10.1038/modpathol.2013.120. Epub 2013 Aug 9.

40.

Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM.

Alvarez-Twose I, Zanotti R, González-de-Olano D, Bonadonna P, Vega A, Matito A, Sánchez-Muñoz L, Morgado JM, Perbellini O, García-Montero A, De Matteis G, Teodósio C, Rossini M, Jara-Acevedo M, Schena D, Mayado A, Zamò A, Mollejo M, Sánchez-López P, Cabañes N, Orfao A, Escribano L; Spanish Network on Mastocytosis (REMA); Italian Network on Mastocytosis (RIMA).

J Allergy Clin Immunol. 2014 Feb;133(2):520-8. doi: 10.1016/j.jaci.2013.06.020. Epub 2013 Aug 6.

PMID:
23921094
41.

Simplification of risk stratification for splenic marginal zone lymphoma: a point-based score for practical use.

Montalban C, Abraira V, Arcaini L, Domingo-Domenech E, Guisado-Vasco P, Iannitto E, Mollejo M, Matutes E, Ferreri AJ, Salar A, Rattotti S, Carpaneto A, Perez R, Bello JL, Hernandez M, Caballero D, Carbonell F, Piris MA; Splenic Marginal Zone Lymphoma Study Group (SMZLSG).

Leuk Lymphoma. 2014 Apr;55(4):929-31. doi: 10.3109/10428194.2013.818143. Epub 2013 Jul 29. No abstract available.

PMID:
23799931
42.

Codeletion of 1p and 19q determines distinct gene methylation and expression profiles in IDH-mutated oligodendroglial tumors.

Mur P, Mollejo M, Ruano Y, de Lope ÁR, Fiaño C, García JF, Castresana JS, Hernández-Laín A, Rey JA, Meléndez B.

Acta Neuropathol. 2013 Aug;126(2):277-89. doi: 10.1007/s00401-013-1130-9. Epub 2013 May 21.

PMID:
23689617
43.

Loss of TCR-beta F1 and/or EZRIN expression is associated with unfavorable prognosis in nodal peripheral T-cell lymphomas.

Rodríguez-Pinilla SM, Sánchez ME, Rodríguez J, García JF, Sánchez-Espiridión B, Lamana LF, Sosa G, Rivero JC, Menárguez J, Gómez IB, Camacho FI, Guillen PR, Orduña CP, Rodríguez G, Barrionuevo C, Franco R, Mollejo M, Marco JF, de Otazu RD, Piris MA.

Blood Cancer J. 2013 Apr 19;3:e111. doi: 10.1038/bcj.2013.10.

44.

Splenic marginal zone lymphoma: comprehensive analysis of gene expression and miRNA profiling.

Arribas AJ, Gómez-Abad C, Sánchez-Beato M, Martinez N, Dilisio L, Casado F, Cruz MA, Algara P, Piris MA, Mollejo M.

Mod Pathol. 2013 Jul;26(7):889-901. doi: 10.1038/modpathol.2012.220. Epub 2013 Feb 22.

45.

Gene expression changes associated with erlotinib response in glioma cell lines.

García-Claver A, Lorente M, Mur P, Campos-Martín Y, Mollejo M, Velasco G, Meléndez B.

Eur J Cancer. 2013 May;49(7):1641-53. doi: 10.1016/j.ejca.2013.01.002. Epub 2013 Jan 30.

PMID:
23374632
46.

Genetic alterations associated with progression and recurrence in meningiomas.

Pérez-Magán E, Campos-Martín Y, Mur P, Fiaño C, Ribalta T, García JF, Rey JA, Rodríguez de Lope A, Mollejo M, Meléndez B.

J Neuropathol Exp Neurol. 2012 Oct;71(10):882-93.

PMID:
22964784
47.

Risk stratification for Splenic Marginal Zone Lymphoma based on haemoglobin concentration, platelet count, high lactate dehydrogenase level and extrahilar lymphadenopathy: development and validation on 593 cases.

Montalbán C, Abraira V, Arcaini L, Domingo-Domenech E, Guisado-Vasco P, Iannitto E, Mollejo M, Matutes E, Ferreri A, Salar A, Rattotti S, Carpaneto A, Pérez Fernández R, Bello JL, Hernández M, Caballero D, Carbonell F, Piris MA; Splenic Marginal Zone Lymphoma Study Group.

Br J Haematol. 2012 Oct;159(2):164-71. doi: 10.1111/bjh.12011. Epub 2012 Aug 24. Erratum in: Br J Haematol. 2013 Sep;162(6):864. Iannito, Emilio [corrected to Iannitto, Emilio].

PMID:
22924582
48.

MicroRNA signatures in B-cell lymphomas.

Di Lisio L, Sánchez-Beato M, Gómez-López G, Rodríguez ME, Montes-Moreno S, Mollejo M, Menárguez J, Martínez MA, Alves FJ, Pisano DG, Piris MA, Martínez N.

Blood Cancer J. 2012 Feb;2(2):e57. doi: 10.1038/bcj.2012.1. Epub 2012 Feb 17.

49.

High-throughput sequencing analysis of the chromosome 7q32 deletion reveals IRF5 as a potential tumour suppressor in splenic marginal-zone lymphoma.

Fresquet V, Robles EF, Parker A, Martinez-Useros J, Mena M, Malumbres R, Agirre X, Catarino S, Arteta D, Osaba L, Mollejo M, Hernandez-Rivas JM, Calasanz MJ, Daibata M, Dyer MJ, Prosper F, Vizcarra E, Piris MÁ, Oscier D, Martinez-Climent JA.

Br J Haematol. 2012 Sep;158(6):712-26. doi: 10.1111/j.1365-2141.2012.09226.x. Epub 2012 Jul 23.

PMID:
22816737
50.

Simultaneous inhibition of pan-phosphatidylinositol-3-kinases and MEK as a potential therapeutic strategy in peripheral T-cell lymphomas.

Martín-Sánchez E, Rodríguez-Pinilla SM, Sánchez-Beato M, Lombardía L, Domínguez-González B, Romero D, Odqvist L, García-Sanz P, Wozniak MB, Kurz G, Blanco-Aparicio C, Mollejo M, Alves FJ, Menárguez J, González-Palacios F, Rodríguez-Peralto JL, Ortiz-Romero PL, García JF, Bischoff JR, Piris MA.

Haematologica. 2013 Jan;98(1):57-64. doi: 10.3324/haematol.2012.068510. Epub 2012 Jul 16.

Supplemental Content

Loading ...
Support Center